These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Featured Prebiotic Agent: The Roles and Mechanisms of Direct and Indirect Prebiotic Activities of Lactoferrin and Its Application in Disease Control. Liu ZS; Chen PW Nutrients; 2023 Jun; 15(12):. PubMed ID: 37375663 [TBL] [Abstract][Full Text] [Related]
8. Potential immune modulating properties and antioxidant activity of supplementing commercially available lactoferrin and/or Lactobacillus sp. in healthy Ossimi lambs. El-Ashker M; Risha E; Abdelhamid F; Ateya A Pol J Vet Sci; 2018 Dec; 21(4):705-713. PubMed ID: 30605288 [TBL] [Abstract][Full Text] [Related]
9. Dual probiotic strains suppress high fructose-induced metabolic syndrome. Park DY; Ahn YT; Huh CS; McGregor RA; Choi MS World J Gastroenterol; 2013 Jan; 19(2):274-83. PubMed ID: 23345951 [TBL] [Abstract][Full Text] [Related]
10. Microencapsulated feruloyl esterase-producing lactobacilli ameliorate lipid profile and glycaemia in high fat diet-induced obese mice. Russo M; Marquez A; Abeijón-Mukdsi MC; Santacruz A; López-Malo A; Gauffin-Cano P; Medina R Benef Microbes; 2019 Mar; 10(2):189-198. PubMed ID: 30525955 [TBL] [Abstract][Full Text] [Related]
11. Effects of heat-inactivated Lactobacillus gasseri TMC0356 on metabolic characteristics and immunity of rats with the metabolic syndrome. Shi L; Li M; Miyazawa K; Li Y; Hiramatsu M; Xu J; Gong C; Jing X; He F; Huang C Br J Nutr; 2013 Jan; 109(2):263-72. PubMed ID: 22717016 [TBL] [Abstract][Full Text] [Related]
12. Anti-Obesity Effects of Zhu K; Tan F; Mu J; Yi R; Zhou X; Zhao X Microorganisms; 2019 Jul; 7(7):. PubMed ID: 31284674 [TBL] [Abstract][Full Text] [Related]
13. Probiotic Lactobacillus gasseri SBT2055 improves glucose tolerance and reduces body weight gain in rats by stimulating energy expenditure. Shirouchi B; Nagao K; Umegatani M; Shiraishi A; Morita Y; Kai S; Yanagita T; Ogawa A; Kadooka Y; Sato M Br J Nutr; 2016 Aug; 116(3):451-8. PubMed ID: 27267802 [TBL] [Abstract][Full Text] [Related]
14. Improvement in glucose tolerance and insulin sensitivity by probiotic strains of Indian gut origin in high-fat diet-fed C57BL/6J mice. Balakumar M; Prabhu D; Sathishkumar C; Prabu P; Rokana N; Kumar R; Raghavan S; Soundarajan A; Grover S; Batish VK; Mohan V; Balasubramanyam M Eur J Nutr; 2018 Feb; 57(1):279-295. PubMed ID: 27757592 [TBL] [Abstract][Full Text] [Related]
15. Lactobacillus fermentum CQPC07 attenuates obesity, inflammation and dyslipidemia by modulating the antioxidant capacity and lipid metabolism in high-fat diet induced obese mice. Wu Y; Li X; Tan F; Zhou X; Mu J; Zhao X J Inflamm (Lond); 2021 Feb; 18(1):5. PubMed ID: 33531053 [TBL] [Abstract][Full Text] [Related]
16. Secretion of Recombinant Interleukin-22 by Engineered Lactobacillus reuteri Reduces Fatty Liver Disease in a Mouse Model of Diet-Induced Obesity. Oh JH; Schueler KL; Stapleton DS; Alexander LM; Yen CE; Keller MP; Attie AD; van Pijkeren JP mSphere; 2020 Jun; 5(3):. PubMed ID: 32581074 [TBL] [Abstract][Full Text] [Related]
18. Anti-obesity effect of Lactobacillus gasseri SBT2055 accompanied by inhibition of pro-inflammatory gene expression in the visceral adipose tissue in diet-induced obese mice. Miyoshi M; Ogawa A; Higurashi S; Kadooka Y Eur J Nutr; 2014; 53(2):599-606. PubMed ID: 23917447 [TBL] [Abstract][Full Text] [Related]
19. Anti-obesity effect of Lactobacillus gasseri BNR17 in high-sucrose diet-induced obese mice. Kang JH; Yun SI; Park MH; Park JH; Jeong SY; Park HO PLoS One; 2013; 8(1):e54617. PubMed ID: 23382926 [TBL] [Abstract][Full Text] [Related]